Joshua Friedman
Corporate Officer/Principal at SPYRE THERAPEUTICS, INC.
Joshua Friedman active positions
| Companies | Position | Start | End |
|---|---|---|---|
| SPYRE THERAPEUTICS, INC. | Corporate Officer/Principal | 27/11/2023 | - |
Career history of Joshua Friedman
Former positions of Joshua Friedman
| Companies | Position | Start | End |
|---|---|---|---|
| SPARK THERAPEUTICS, INC. | Corporate Officer/Principal | 01/01/2022 | 01/07/2023 |
| ALNYLAM PHARMACEUTICALS, INC. | Corporate Officer/Principal | 01/11/2019 | 01/01/2022 |
Training of Joshua Friedman
| Harvard University | Undergraduate Degree |
| University of Pennsylvania | Doctorate Degree |
Statistics
International
| United States | 6 |
Operational
| Corporate Officer/Principal | 3 |
| Undergraduate Degree | 1 |
| Doctorate Degree | 1 |
Sectoral
| Health Technology | 4 |
| Consumer Services | 3 |
Positions held
Active
Inactive
Listed companies
Private companies
Linked companies
| Listed companies | 2 |
|---|---|
| SPYRE THERAPEUTICS, INC. | Health Technology |
| ALNYLAM PHARMACEUTICALS, INC. | Health Technology |
| Private companies | 1 |
|---|---|
Spark Therapeutics, Inc.
 Spark Therapeutics, Inc. BiotechnologyHealth Technology Spark Therapeutics, Inc. engages in the research, development, and commercialization of gene therapies. Its product portfolio intends to treat inherited retinal sickness, liver-mediated, and neurodegenerative diseases. The company was founded by Jean Bennett, Beverly Davidson, Katherine A. High, Jeffrey D. Marrazzo, J. Fraser Wright, and Jennifer Wellman on March 13, 2013 and is headquartered in Philadelphia, PA. | Health Technology |
- Stock Market
- Insiders
- Joshua Friedman
- Experience
